Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xeris Pharmaceuticals Inc

4.90
-0.0500-1.01%
Post-market: 4.900.00000.00%19:30 EDT
Volume:1.60M
Turnover:7.85M
Market Cap:784.76M
PE:-16.28
High:5.03
Open:5.00
Low:4.84
Close:4.95
Loading ...
Mar 11, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 21, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, items 2.02 and 8.01
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 08, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 01, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Sep 10, 2019

Major Issues Report

Current report, items 1.01, 2.03, 8.01, and 9.01
Aug 19, 2019

Correspondence

[Cover]Correspondence
Aug 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities